Skip to main content
. 2022 Nov 9;613(7944):558–564. doi: 10.1038/s41586-022-05514-2

Extended Data Fig. 1. Growth assays with SARS-CoV-2 passaged in Vero E6 cells.

Extended Data Fig. 1

a-d, Growth was quantified for lineage A (a), lineage B (b), lineage C (c), and unpassaged SARS-CoV-2 (d, denoted as WT-P0) in comparison to SARS-CoV-2 passaged without nirmatrelvir for 30 passages (denoted as WT-P30). Vero E6 cells were infected with 200 TCID50 of the indicated viruses and viral RNA was quantified at the indicated time points. e, The slope during the exponential phase (between 11 and 24 h post-infection) of growth for the indicated viruses.